These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33004331)

  • 1. Genomic Risk Score impact on susceptibility to systemic sclerosis.
    Bossini-Castillo L; Villanueva-Martin G; Kerick M; Acosta-Herrera M; López-Isac E; Simeón CP; Ortego-Centeno N; Assassi S; ; ; ; ; Hunzelmann N; Gabrielli A; de Vries-Bouwstra JK; Allanore Y; Fonseca C; Denton CP; Radstake TR; Alarcón-Riquelme ME; Beretta L; Mayes MD; Martin J
    Ann Rheum Dis; 2021 Jan; 80(1):118-127. PubMed ID: 33004331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wongthanee A; Kuwata S; Takeuchi F
    Int J Rheum Dis; 2021 Nov; 24(11):1378-1385. PubMed ID: 34533895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.
    Yi L; Wang JC; Guo XJ; Gu YH; Tu WZ; Guo G; Yang L; Xiao R; Yu L; Mayes MD; Assassi S; Jin L; Zou HJ; Zhou XD
    Int J Immunopathol Pharmacol; 2013; 26(2):473-478. PubMed ID: 23755762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis.
    Koumakis E; Bouaziz M; Dieudé P; Ruiz B; Riemekasten G; Airo P; Müller-Nurasyid M; Cusi D; Matucci-Cerinic M; Melchers I; Salvi E; Strauch K; Peters A; Cuomo G; Hachulla E; Diot E; Hunzelmann N; Caramaschi P; Riccieri V; Distler JH; Tarner I; Avouac J; Letenneur L; Amouyel P; Lambert JC; Chiocchia G; Boileau C; Allanore Y
    Arthritis Rheum; 2013 Dec; 65(12):3202-8. PubMed ID: 23983073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
    Gorlova O; Martin JE; Rueda B; Koeleman BP; Ying J; Teruel M; Diaz-Gallo LM; Broen JC; Vonk MC; Simeon CP; Alizadeh BZ; Coenen MJ; Voskuyl AE; Schuerwegh AJ; van Riel PL; Vanthuyne M; van 't Slot R; Italiaander A; Ophoff RA; Hunzelmann N; Fonollosa V; Ortego-Centeno N; González-Gay MA; García-Hernández FJ; González-Escribano MF; Airo P; van Laar J; Worthington J; Hesselstrand R; Smith V; de Keyser F; Houssiau F; Chee MM; Madhok R; Shiels PG; Westhovens R; Kreuter A; de Baere E; Witte T; Padyukov L; Nordin A; Scorza R; Lunardi C; Lie BA; Hoffmann-Vold AM; Palm O; García de la Peña P; Carreira P; ; Varga J; Hinchcliff M; Lee AT; Gourh P; Amos CI; Wigley FM; Hummers LK; Nelson JL; Riemekasten G; Herrick A; Beretta L; Fonseca C; Denton CP; Gregersen PK; Agarwal S; Assassi S; Tan FK; Arnett FC; Radstake TR; Mayes MD; Martin J
    PLoS Genet; 2011 Jul; 7(7):e1002178. PubMed ID: 21779181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis.
    McKinney C; Broen JC; Vonk MC; Beretta L; Hesselstrand R; Hunzelmann N; Riemekasten G; Scorza R; Simeon CP; Fonollosa V; Carreira PE; Ortego-Centeno N; Gonzalez-Gay MA; Airo P; Coenen M; Martin J; Radstake TR; Merriman TR
    Genes Immun; 2012 Sep; 13(6):458-60. PubMed ID: 22551723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.
    Diaz-Gallo LM; Simeon CP; Broen JC; Ortego-Centeno N; Beretta L; Vonk MC; Carreira PE; Vargas S; Román-Ivorra JA; González-Gay MA; Tolosa C; López-Longo FJ; Espinosa G; Vicente EF; Hesselstrand R; Riemekasten G; Witte T; Distler JH; Voskuyl AE; Schuerwegh AJ; Shiels PG; Nordin A; Padyukov L; Hoffmann-Vold AM; Scorza R; Lunardi C; Airo P; van Laar JM; Hunzelmann N; Gathof BS; Kreuter A; Herrick A; Worthington J; Denton CP; Zhou X; Arnett FC; Fonseca C; Koeleman BP; Assasi S; Radstake TR; Mayes MD; Martín J;
    Ann Rheum Dis; 2013 Jul; 72(7):1233-8. PubMed ID: 23172754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DPB1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjögren's syndrome and progressive systemic sclerosis: a question of disease relevance.
    Reveille JD; Brady J; MacLeod-St Clair M; Durban E
    Tissue Antigens; 1992 Jul; 40(1):45-8. PubMed ID: 1440561
    [No Abstract]   [Full Text] [Related]  

  • 15. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
    Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
    J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.
    Ochoa E; Martin JE; Assasi S; Beretta L; Carreira P; Guillén A; Simeón CP; Koumakis E; Dieude P; Allanore Y; García-Hernández FJ; Espinosa G; Castellví I; Trapiella JL; Rodriguez L; González-Gay MÁ; Egurbide MV; Sáez L; Callejas-Rubio JL; Vargas-Hitos JA; Hunzelmann N; Riemekasten G; Witte T; Distler JH; Kreuter A; Lunardi C; Santaniello A; Tan FK; Shiels PG; Herrick A; Worthington J; Vonk MC; Koeleman BP; Radstake TR; Mayes MD; Martin J;
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S31-5. PubMed ID: 26314374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological features of systemic sclerosis in a Chinese cohort.
    Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
    Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zmorzyński S; Wojcierowska-Litwin M; Kowal M; Michalska-Jakubus M; Styk W; Filip AA; Walecka I; Krasowska D
    Biomed Res Int; 2020; 2020():8465971. PubMed ID: 32185220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.
    Broen J; Gourh P; Rueda B; Coenen M; Mayes M; Martin J; Arnett FC; Radstake TR;
    Arthritis Rheum; 2009 Dec; 60(12):3815-20. PubMed ID: 19950259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.
    Carmona FD; Serrano A; Rodríguez-Rodríguez L; Callejas JL; Simeón CP; Carreira P; Castañeda S; Solans R; Blanco R; ; ; González-Gay MA; Martín J
    J Rheumatol; 2012 Jun; 39(6):1275-9. PubMed ID: 22589256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.